CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

RBC Adjusts PT on Pharvaris to $52 From $51, Maintains Outperform Speculative Risk Rating

Neutral
AI Analysis

Summary

RBC adjusted its price target on Pharvaris to $52 from $51 while maintaining an Outperform speculative risk rating.

Importance:2/10
Sentiment:
0.10
analyst_ratingprice_target
Related Companies

Read the original article

Published by yahoo_finance on August 13, 2026 10:51 AM

Read Original